Related Experiment Video
Updated: Sep 28, 2025

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.9K
Prime time for doxorubicin-induced cardiotoxicity genetic testing
Tarek Magdy1,2, Paul W Burridge1,2
1Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Pharmacogenomics
|April 5, 2022
Summary
No abstract available in PubMed .
Keywords:
cardiotoxicitychemotherapyclinical translationhuman-induced pluripotent stem cellspharmacogenomicsMore Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
75
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
75
Cardiomyopathy II: Dilated Cardiomyopathy
43
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
43

